Literature DB >> 8060825

Oral cancer.

S Silverman1.   

Abstract

Oral cancer currently strikes about 31,000 Americans each year. Survival rates are approximately 50%. However, early detection followed by appropriate treatment can increase cure rates to about 80%, and greatly improves the quality of life by minimizing extensive, debilitating treatments. An early oral cancer can appear as an innocuous red or white change, an ulcer, or a lump, mimicking many benign lesions. Additionally, when the discomfort is minimal, professional consultation is often delayed, increasing the chance for local spread and regional metastases. Vital staining with toluidine blue and exfoliative cytological examination can aid early detection by accelerating the biopsy of lesions that cannot be classified adequately or made to disappear.

Entities:  

Mesh:

Year:  1994        PMID: 8060825

Source DB:  PubMed          Journal:  Semin Dermatol        ISSN: 0278-145X


  4 in total

1.  Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis.

Authors:  V Patel; A M Senderowicz; D Pinto; T Igishi; M Raffeld; L Quintanilla-Martinez; J F Ensley; E A Sausville; J S Gutkind
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

2.  The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects.

Authors:  D L Mager; A D Haffajee; P M Devlin; C M Norris; M R Posner; J M Goodson
Journal:  J Transl Med       Date:  2005-07-07       Impact factor: 5.531

3.  Bacteria and cancer: cause, coincidence or cure? A review.

Authors:  D L Mager
Journal:  J Transl Med       Date:  2006-03-28       Impact factor: 5.531

4.  The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscope™) - a single blinded clinical evaluation.

Authors:  Henning Hanken; Juliane Kraatz; Ralf Smeets; Max Heiland; Alexandre Thomas Assaf; Marco Blessmann; Wolfgang Eichhorn; Till Sebastian Clauditz; Alexander Gröbe; Andreas Kolk; Madiha Rana
Journal:  Head Face Med       Date:  2013-08-23       Impact factor: 2.151

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.